CREATING A POSITIVE IMPACT
Patients are at the heart of our strategy, and we take seriously our responsibility to make a positive contribution to society.
Our patient-centricity empowers us in creating and delivering innovations with real impact. We are fully focused on Specialty Care across three therapeutic areas: Oncology, Rare Disease and Neuroscience. We are also committed to supporting our communities, employees and the environment, and creating lasting positive change. We have implemented Generation Ipsen, a robust ESG framework that will enable each of us to think big as we strive to benefit all society.
Key facts
Our team of over 5,200 talented and dedicated professionals around the world works together every day to innovate for the benefit of patients and caregivers, while creating impact for people and the planet.
€1.5 M
donated to humanitarian relief funds in 2022
241+
patient organizations collaborated with Ipsen in 2022
48%
percentage of women making up the Global Leadership Team
90%
renewable energy for our global operations
What gets me out of bed in the morning is my commitment to Ipsen and my colleagues, to scientific knowledge and to the best possible treatment to improve patients’ lives.
How we help
We believe in empowering our teams so they can contribute with passion and care to address patients’ challenges.
Oncology
Our Oncology teams bring deep expertise in cancer and focus on delivering medicines that help people live longer and live well.
Rare Disease
Ipsen is dedicated to developing innovative medicines for rare diseases, focusing on three main areas: bone and endocrine, neuromuscular and liver.
Neuroscience
At the forefront of neurotoxins research, we are broadening our neuroscience capabilities to respond to patients’ unmet needs.